FDA Approves Merck’s Welireg (Belzutifan) for Renal Cell Carcinoma Treatment

FDA Approves Merck’s Welireg (Belzutifan) for Renal Cell Carcinoma Treatment

In a significant development, the U.S. Food and Drug Administration (FDA) granted approval on Thursday for Merck’s drug belzutifan, marketed…